223250 — DreamCIS Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapContrarian

Annual income statement for DreamCIS, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	23,489	26,153	38,874	47,844	58,653
Cost of Revenue
Gross Profit	9,617	8,691	13,865	12,939	17,862
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	18,695	22,532	33,141	46,256	53,596
Operating Profit	4,794	3,621	5,732	1,588	5,057
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,900	3,945	5,155	4,406	6,184
Provision for Income Taxes
Net Income After Taxes	4,854	3,229	4,522	3,858	5,413
Minority Interest
Net Income Before Extraordinary Items
Net Income	4,854	3,229	4,405	3,739	5,280
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,854	3,229	4,405	3,739	5,280
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	238	143	197	157	221
Dividends per Share